These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 14601096

  • 1. Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumors.
    Vogt T, Hafner C, Bross K, Bataille F, Jauch KW, Berand A, Landthaler M, Andreesen R, Reichle A.
    Cancer; 2003 Nov 15; 98(10):2251-6. PubMed ID: 14601096
    [Abstract] [Full Text] [Related]

  • 2. Pioglitazone and rofecoxib combined with angiostatically scheduled trofosfamide in the treatment of far-advanced melanoma and soft tissue sarcoma.
    Reichle A, Bross K, Vogt T, Bataille F, Wild P, Berand A, Krause SW, Andreesen R.
    Cancer; 2004 Nov 15; 101(10):2247-56. PubMed ID: 15470711
    [Abstract] [Full Text] [Related]

  • 3. Targeted combined anti-inflammatory and angiostatic therapy in advanced melanoma: a randomized phase II trial.
    Reichle A, Vogt T, Coras B, Terheyden P, Neuber K, Trefzer U, Schultz E, Berand A, Bröcker EB, Landthaler M, Andreesen R.
    Melanoma Res; 2007 Dec 15; 17(6):360-4. PubMed ID: 17992118
    [Abstract] [Full Text] [Related]

  • 4. A new therapeutic approach in patients with advanced sarcoma.
    Kasper B, Ho AD, Egerer G.
    Int J Clin Oncol; 2005 Dec 15; 10(6):438-40. PubMed ID: 16369750
    [Abstract] [Full Text] [Related]

  • 5. Antiangiogenic therapy with pioglitazone, rofecoxib, and trofosfamide in a patient with endemic kaposi sarcoma.
    Coras B, Hafner C, Reichle A, Hohenleutner U, Szeimies RM, Landthaler M, Vogt T.
    Arch Dermatol; 2004 Dec 15; 140(12):1504-7. PubMed ID: 15611430
    [Abstract] [Full Text] [Related]

  • 6. Phase II clinical trial results involving treatment with low-dose daily oral cyclophosphamide, weekly vinblastine, and rofecoxib in patients with advanced solid tumors.
    Young SD, Whissell M, Noble JC, Cano PO, Lopez PG, Germond CJ.
    Clin Cancer Res; 2006 May 15; 12(10):3092-8. PubMed ID: 16707607
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults.
    Kesari S, Schiff D, Doherty L, Gigas DC, Batchelor TT, Muzikansky A, O'Neill A, Drappatz J, Chen-Plotkin AS, Ramakrishna N, Weiss SE, Levy B, Bradshaw J, Kracher J, Laforme A, Black PM, Folkman J, Kieran M, Wen PY.
    Neuro Oncol; 2007 Jul 15; 9(3):354-63. PubMed ID: 17452651
    [Abstract] [Full Text] [Related]

  • 11. Phase II trial of trofosfamide in patients with advanced pretreated soft tissue sarcomas.
    Hartmann JT, Oechsle K, Mayer F, Kanz L, Bokemeyer C.
    Anticancer Res; 2003 Jul 15; 23(2C):1899-901. PubMed ID: 12820475
    [Abstract] [Full Text] [Related]

  • 12. High-Dose celecoxib and metronomic "low-dose" cyclophosphamide is an effective and safe therapy in patients with relapsed and refractory aggressive histology non-Hodgkin's lymphoma.
    Buckstein R, Kerbel RS, Shaked Y, Nayar R, Foden C, Turner R, Lee CR, Taylor D, Zhang L, Man S, Baruchel S, Stempak D, Bertolini F, Crump M.
    Clin Cancer Res; 2006 Sep 01; 12(17):5190-8. PubMed ID: 16951238
    [Abstract] [Full Text] [Related]

  • 13. Octreotide alone or in combination with rofecoxib as palliative treatment for advanced hepatocellular cancer.
    Treiber G, Röcken C, Wex T, Malfertheiner P.
    Z Gastroenterol; 2007 May 01; 45(5):369-77. PubMed ID: 17503315
    [Abstract] [Full Text] [Related]

  • 14. Vinorelbine and low-dose cyclophosphamide in the treatment of pediatric sarcomas: pilot study for the upcoming European Rhabdomyosarcoma Protocol.
    Casanova M, Ferrari A, Bisogno G, Merks JH, De Salvo GL, Meazza C, Tettoni K, Provenzi M, Mazzarino I, Carli M.
    Cancer; 2004 Oct 01; 101(7):1664-71. PubMed ID: 15378498
    [Abstract] [Full Text] [Related]

  • 15. Prolonged clinical benefit with metronomic chemotherapy in patients with metastatic breast cancer.
    Orlando L, Cardillo A, Rocca A, Balduzzi A, Ghisini R, Peruzzotti G, Goldhirsch A, D'Alessandro C, Cinieri S, Preda L, Colleoni M.
    Anticancer Drugs; 2006 Sep 01; 17(8):961-7. PubMed ID: 16940806
    [Abstract] [Full Text] [Related]

  • 16. Prednisone, etoposide, procarbazine, and cyclophosphamide (PEP-C) oral combination chemotherapy regimen for recurring/refractory lymphoma: low-dose metronomic, multidrug therapy.
    Coleman M, Martin P, Ruan J, Furman R, Niesvizky R, Elstrom R, George P, Kaufman TP, Leonard JP.
    Cancer; 2008 May 15; 112(10):2228-32. PubMed ID: 18338745
    [Abstract] [Full Text] [Related]

  • 17. Rituximab combined with cladribine or with cladribine and cyclophosphamide in heavily pretreated patients with indolent lymphoproliferative disorders and mantle cell lymphoma.
    Robak T, Smolewski P, Cebula B, Szmigielska-Kaplon A, Chojnowski K, Blonski JZ.
    Cancer; 2006 Oct 01; 107(7):1542-50. PubMed ID: 16948126
    [Abstract] [Full Text] [Related]

  • 18. Treatment of 72 newly diagnosed Waldenstrom macroglobulinemia cases with oral melphalan, cyclophosphamide, and prednisone: results and cost analysis.
    Annibali O, Petrucci MT, Martini V, Tirindelli MC, Levi A, Fossati C, Del Bianco P, Mandelli F, Foa R, Avvisati G.
    Cancer; 2005 Feb 01; 103(3):582-7. PubMed ID: 15611977
    [Abstract] [Full Text] [Related]

  • 19. Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor?
    Banna GL, De Giorgi U, Ferrari B, Castagna L, Alloisio M, Marangolo M, Rosti G, Santoro A.
    Biol Blood Marrow Transplant; 2006 Oct 01; 12(10):1085-91. PubMed ID: 17084372
    [Abstract] [Full Text] [Related]

  • 20. A phase II trial of continuous low-dose oral cyclophosphamide and celecoxib in patients with renal cell carcinoma.
    Krzyzanowska MK, Tannock IF, Lockwood G, Knox J, Moore M, Bjarnason GA.
    Cancer Chemother Pharmacol; 2007 Jun 01; 60(1):135-41. PubMed ID: 17009033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.